Liquid biopsies are becoming essential in the lung cancer arena.
Liquid biopsies are becoming an integral part of the diagnosis and treatment planning for patients with lung cancer, explained Adijan Kuckovic, a graduate student researcher at the University of Illinois College of Medicine at Rockford.
Patients undergoing a liquid biopsy will first have their blood and platelets drawn. Then, the DNA will be isolated, and expression panels will be run to see if the person has certain cancer markers. The process is currently one of the most highly specific technologies available in the lung cancer space.
Aumolertinib Plus SRT Achieves Intracranial Responses in Oligometastatic EGFR+ NSCLC
May 10th 2023Prospective phase 2 data demonstrated that aumolertinib, followed by salvage stereotactic radiation therapy, elicited responses in patients with intracranial oligometastatic EGFR-mutant non–small cell lung cancer.
Are Hearing Tests Necessary For Adult Cancer Survivors?
September 15th 2022In this episode of “The Vitals,” Christine Miaskowski, PhD, RN, discusses research showcasing that adult patients receiving either a platinum-based chemotherapy, taxane alone, or a combined regimen of platinum- and taxane-based treatment may be at risk of hearing loss.
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
Improvements in Health Systems Model Reduces Disparities in Leukemia Survival in Low-Income Countries
Telephone and Web-Based Program Elicits Clinically Meaningful Results in Breast Cancer Survivors
Luspatercept Elicits High Transfusion Independence Rates in Lower-Risk MDS
2 Clarke Drive
Cranbury, NJ 08512